(Q38098448)

28 August 2017

title

Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system (English)

1 reference

28 August 2017

main subject

mesenchymal stem cell

1 reference

0 references

Antonio Uccelli

4

0 references

author name string

Alice Laroni

series ordinal

1

1 reference

28 August 2017

Giovanni Novi

series ordinal

2

1 reference

28 August 2017

Nicole Kerlero de Rosbo

series ordinal

3

1 reference

28 August 2017

publication date

12 April 2013

1 reference

Journal of Neuroimmune Pharmacology

28 August 2017

published in

1 reference

28 August 2017

volume

8

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

1062-1076

1 reference

Remyelination of the spinal cord following intravenous delivery of bone marrow cells

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Transplanted bone marrow mesenchymal stem cells improve memory in rat models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Autologous mesenchymal stem cells in chronic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Invited Article: Nervous system pathology in sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells as trophic mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Role of the innate immune system in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Amyloid beta-derived neuroplasticity in bone marrow-derived mesenchymal stem cells is mediated by NPY and 5-HT2B receptors via ERK1/2 signalling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

A randomized trial of mesenchymal stem cells in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Treatment of stroke in rat with intracarotid administration of marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

A novel cell transplantation protocol and its application to an ALS mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Atorvastatin: an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Protection of dopamine neurons by bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Sarcoma derived from cultured mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Multiple system atrophy: a clinical and neuropathological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Progesterone enhances immunoregulatory activity of human mesenchymal stem cells via PGE2 and IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9456-6

Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use

21 January 2018

1 reference

12 December 2020

Mesenchymal stem cells as treatment for MS - progress to date.

1 reference

12 December 2020

Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells

1 reference

12 December 2020

Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatc

1 reference

12 December 2020

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

1 reference

12 December 2020

Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models.

1 reference

12 December 2020

Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study

1 reference

12 December 2020

Comparative effects between bone marrow and mesenchymal stem cell transplantation in GDNF expression and motor function recovery in a motorneuron degenerative mouse model.

1 reference

12 December 2020

Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice

1 reference

12 December 2020

Stem cell treatment in Amyotrophic Lateral Sclerosis

1 reference

12 December 2020

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

1 reference

12 December 2020

Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis

1 reference

12 December 2020

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

1 reference

12 December 2020

Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo.

1 reference

12 December 2020

1 reference

12 December 2020

Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report

1 reference

12 December 2020

Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease.

1 reference

12 December 2020

Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study

1 reference

12 December 2020

Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease

1 reference

12 December 2020

Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function

1 reference

12 December 2020

Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses.

1 reference

12 December 2020

Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Autologous mesenchymal stem cell transplantation in stroke patients

1 reference

12 December 2020

Bone marrow stromal cells as replacement cells for Parkinson's disease: generation of an anatomical but not functional neuronal phenotype

1 reference

12 December 2020

Administration of cultured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: a pilot study

1 reference

12 December 2020

Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans

1 reference

12 December 2020

Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis

1 reference

12 December 2020

Specification of a dopaminergic phenotype from adult human mesenchymal stem cells

1 reference

12 December 2020

Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma

1 reference

12 December 2020

Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease

1 reference

12 December 2020

10.1007/S11481-013-9456-6

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1037722248

0 references

1 reference